Invasive breast cancer incidence rates according to stage at diagnosis (panel a) and oestrogen receptor status (panel b) 1997–2000

<p><b>Copyright information:</b></p><p>Taken from "Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy"</p><p>BMC Cancer 2006;6():78-78.</p><p>Published online 22 Mar 2006</p><p>PMCID:PMC1440868.</p><p>Copyright © 2006 Bouchardy et al; licensee BioMed Central Ltd.</p> Panel a. Panel b

Invasive breast cancer incidence rates by age and period, Geneva cancer registry 1975–2003

<p><b>Copyright information:</b></p><p>Taken from "Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy"</p><p>BMC Cancer 2006;6():78-78.</p><p>Published online 22 Mar 2006</p><p>PMCID:PMC1440868.</p><p>Copyright © 2006 Bouchardy et al; licensee BioMed Central Ltd.</p

Invasive breast cancer incidence according to ever use of hormone replacement therapy (HRT) and detection by mammography screening, 1997–2000

<p><b>Copyright information:</b></p><p>Taken from "Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy"</p><p>BMC Cancer 2006;6():78-78.</p><p>Published online 22 Mar 2006</p><p>PMCID:PMC1440868.</p><p>Copyright © 2006 Bouchardy et al; licensee BioMed Central Ltd.</p> As information on HRT use was available for 46% of all breast cancer patients, breast cancer incidence rates are approximately half of the overall breast cancer incidence rates during the period 1997–2000

Respondent Characteristics by Survey Year Among Adults 50–75 years of age from Swiss Health Interview Survey 2007 and 2012 (n = 13,170).

<p>¹ Proportions are weighted.</p><p>² Unweighted Pearson Chi-square test.</p><p>³ In October 2014, $1US Dollar = 1 CHF = 0.8 EUR.</p><p>^4.Missing on 570 respondents</p><p>⁵ Missing on 208 respondents.</p><p>Respondent Characteristics by Survey Year Among Adults 50–75 years of age from Swiss Health Interview Survey 2007 and 2012 (n = 13,170).</p

Colorectal Cancer Screening Weighted Prevalence among Respondents Aged 50–75 years of age from Swiss Health Interview Survey 2007–2012.

<p>Hemoccult in past 2 years 2007 vs 2012 (p-value = 0.002). Endoscopy in past 10 years 2007 vs 2012 (p-value<0.001). Any CRC screening (Hemoccult in past 2 years or endoscopy in past 10 years or both) 2007 vs 2012 (p-value = 0.036). P-values are adjusted for education, household income, employment, age, sex, marital status, citizenship, urban/rural status, health status and health care use.</p

Adjusted and weighted prevalence ratios of colorectal cancer screening among adults aged 50–75 from the Swiss Health Interview Survey 2007 and 2012 (n = 13,170).

<p>1. P-value for time-trend were estimated as follow: for each predictor (education, income, etc.), we estimated separately one multivariate model including all predictors plus the interaction term between the predictor and the wave. We reported only the p-value. 2. Prevalence ratios are adjusted for all variables in the table as well as for health statues which included self-rated health, body mass index, physical symptoms, psychological distress, hospitalization and smoking. Ref: reference category</p><p>Adjusted and weighted prevalence ratios of colorectal cancer screening among adults aged 50–75 from the Swiss Health Interview Survey 2007 and 2012 (n = 13,170).</p